Vimentin Antikörper (FITC)

Produktnummer ABIN112308

Dieses Anti-Vimentin-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Vimentin in WB, IF, FACS, IHC (p), IHC (fro) und EIA. Geeignet für Human, Rind (Kuh), Huhn, Affe, Hund und Amphibien.

Kurzübersicht für Vimentin Antikörper (FITC) (ABIN112308)

Target: Vimentin (VIM)

Reaktivität: Human, Rind (Kuh), Huhn, Affe, Hund, Amphibien

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Vimentin Antikörper ist konjugiert mit FITC

Applikation: Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)

Klon: VIM 3B4

Produktdetails anti-Vimentin Antikörper (FITC)

Spezifität: This antibody is highly specific for the intermediate filament protein Vimentin. Polypeptide reacting: Mr 57 000 intermediate filament protein (Vimentin) of mesenchymal cells. The binding region of monoclonal antibody VIM3B4 has been characterized by Bohn et al. (1992). According to these authors, the epitope has been localized on the alpha-helical part of Vimentin (rod domain coil 2). Due to an aa substitution at position of aa 353 in murine Vimentin (that could explain for the weak cross-reaction of the antibody with murine Vimentin) they were able to narrow down the binding region around position 353. These findings were confirmed by truncation mutagenesis experiments using Human Vimentin (Rogers et al., 1995). Clone VIM 3B4 has turned out to be the most avid mab to Vimentin. Tumors Specifically Detected: Sarcoma (including myosarcoma), lymphoma, melanoma. Tested Reactivities on Cultured Cell Lines: RD cells, glioma cells, fibroblasts (SV-80), MDCK.

Kreuzreaktivität (Details): Species reactivity (tested):Human, Monkey, Bovine, Dog, Chicken, Amphibian (e.g. Xenopus leavis). Weaker Murine cross-reaction.

Aufreinigung: Affinity Chromatography on Protein A

Immunogen: Vimentin (purified from Bovine lens)

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: ELISA. Immunoblotting. Flow Cytometry. Immunofluorescence Microscopy (5-10 μg/mL recommended)Immunohistochemistry (dilute at least 1/10 with PBS, pH 7.4). Suitable for Frozen and Paraffin-Embedded tissue and Cytological Material. Withparaffin-embedded sections, protease pretreatment is required prior to antibodyapplication. Incubation Time: 1 h at RT, extended with paraffin.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Vimentin

Target: Vimentin (VIM)

Andere Bezeichnung: Vimentin

Hintergrund: Vimentin is an intermediate filament protein which is present in all cells of mesenchymal origin. Vimentin is the major subunit protein of the intermediate filaments of mesenchymal cells. It is believed to be involved with the intracellular transport of proteins between the nucleus and plasma membrane. Vimentin has been implicated to be involved in the rate of steroid synthesis via its role as a storage network for steroidogenic cholesterol containing lipid droplets. Vimentin phosphorylation by a protein kinase causes the breakdown of intermediate filaments and activation of an ATP and myosin light chain dependent contractile event. This results in cytoskeletal changes that facilitate the interaction of the lipid droplets within mitochondria, and subsequent transport of cholesterol to the organelles leading to an increase in steroid synthesis. Immunohistochemical staining for Vimentin is characteristic of sarcomas (of neural, muscle and fibroblast origin) compared to carcinomas which are generally negative. Melanomas, lymphomas and vascular tumors may all stain for Vimentin. Vimentin antibodies are thus of value in the differential diagnosis of undifferentiated neoplasms and malignant tumors. They are generally used with a panel of other antibodies including those recognizing cytokeratins, lymphoid markers, S100, desmin and neurofilaments.Synonyms: VIM

Gen-ID: 7431

NCBI Accession: NP_003371

UniProt: P08670

Pathways: Caspase Kaskade in der Apoptose